Literature DB >> 8521167

The NAASO position paper on approval and use of drugs to treat obesity.

X Pi-Sunyer.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8521167     DOI： 10.1002/j.1550-8528.1995.tb00177.x

Source DB:  PubMed          Journal:  Obes Res        ISSN： 1071-7323


× No keyword cloud information.
  3 in total

Review 1.  A risk-benefit assessment of anti-obesity drugs.

Authors:  J Kolanowski
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 2.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 3.  Sibutramine. A review of its contribution to the management of obesity.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.